Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for ADGM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 -0.415M
March 31, 2026 5.725M
December 31, 2025 12.40M
September 30, 2025 -1.312M
June 30, 2025 8.666M
March 31, 2025 12.40M
December 31, 2024 19.91M
September 30, 2024 76.56M
June 30, 2024 -140.51M
March 31, 2024 -141.48M
December 31, 2023 25.68M
Date Value
September 30, 2023 27.90M
June 30, 2023 28.36M
March 31, 2023 27.98M
December 31, 2022 -95.88M
September 30, 2022 141.98M
June 30, 2022 138.80M
March 31, 2022 138.99M
December 31, 2021 139.20M
September 30, 2021 140.30M
June 30, 2021 145.39M
March 31, 2021 145.56M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 51.11B
AngioDynamics, Inc. 170.82M
Alphatec Holdings, Inc. 11.53M
AtriCure, Inc. 516.43M
Baxter International, Inc. 6.206B

Shareholders Equity (Quarterly) Related Metrics